Korea S.E.
06:00:00 2024-05-30 pm EDT
5-day change
1st Jan Change
1,044
KRW
-.--%
-7.45%
-37.93%
KMH Akyung Group cancelled the acquisition of unknown stake in Kyung Nam Pharm Co., Ltd..
KMH Akyung Group was selected as preferred bidder to acquire unknown stake in Kyung Nam Pharm Co., Ltd. (KOSDAQ:A053950) on June 4, 2018.
KMH Akyung Group cancelled the acquisition of unknown stake in Kyung Nam Pharm Co., Ltd. (KOSDAQ:A053950) on June 29, 2018. The Board of Directors of Kyung Nam Pharm Co., Ltd. passed a decision disclosing sales M&A withdrawal decision on June 29, 2018.
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
23-09-21
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
23-09-17
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding
23-08-09
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding
23-07-16
CI
Kyung Nam Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Kyung Nam Pharm Co.,Ltd. agreed to acquire 9.94% stake in ILYA Co., Ltd from Kang, Jae Woo and Han, Seung Ja for KRW 7 billion.
23-03-14
CI
Enterpartners Co., LTD announced that it expects to receive KRW 26.599899939 billion in funding from Kyung Nam Pharm Co.,Ltd.
22-11-13
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD.
21-12-23
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
21-12-09
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 8 billion in funding from Metaplex Co., Ltd., and other investors
21-11-29
CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
21-07-19
CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd.
21-07-11
CI
Kyung Nam Pharm Co.,Ltd., Virtualtek Corp and Ventage Partners Co., Ltd. agreed to acquire 9.32% stake in Livefinancial Co.,Ltd. for KRW 5.8 billion.
20-07-15
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 1.9999997 billion in funding from KyungNam Biopharma CO.,LTD.
20-06-30
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
20-06-09
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 14.5 billion in funding from Kartoon Korea CO.,LTD. and other investors
20-06-03
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 1.9999997 billion in funding from BioGenetics CO.,LTD.
20-03-29
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.
19-05-22
CI
Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 6.49999411 billion in funding from BioGenetics CO.,LTD.
19-05-20
CI
BioGenetics CO.,LTD. acquired additional unknown stake in Kyung Nam Pharm Co.,Ltd. for KRW 22.5 billion.
19-05-12
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 20.49998703 billion in funding from BioGenetics CO.,LTD., Liveplex Co.,Ltd., CTGen Co.,Ltd., Widwin Investment Co., Ltd.
19-05-12
CI
Kyung Nam Pharm Co., Ltd. announced that it has received KRW 10.534998926 billion in funding
18-11-13
CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 6.499998976 billion in funding from BioGenetics CO.,LTD.
18-11-13
CI
Kyung Nam Pharm Co., Ltd. announced that it expects to receive KRW 16.99999501 billion in funding
18-10-14
CI
KMH Akyung Group cancelled the acquisition of unknown stake in Kyung Nam Pharm Co., Ltd..
18-06-28
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KYUNG NAM PHARM.CO., LTD. is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The Company provides vitamin products under the brand name LEMONA. It supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.
More about the company
1st Jan change
Capi.
-37.93% 26.87M +15.91% 41.97B +22.40% 22.34B +18.48% 15.25B +16.12% 14B +45.12% 12.06B -9.58% 6.8B -0.05% 6.79B -8.87% 5.73B +14.18% 5.49B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KYUNG NAM PHARM CO.,LTD. 
